688166 Brightgene Bio-Medical Technology Co.,Ltd.
- 34.48
- -0.15-0.43%
Brightgene Bio-Medical Technology Co.,Ltd. News
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on the 2023 Annual General Meeting of Shareholders of Borui Biopharmaceuticals (Suzhou) Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Investor Research Report April 28, 2024 to May 8, 2024
An indicative announcement on the disclosure of plans to issue A-shares to specific targets in 2024
Feasibility analysis report on the use of capital raised by issuing A-shares to specific targets in 2024
Written review opinions of the board of supervisors on matters relating to the issuance of A-shares by the company to specific targets in 2024
An empirical analysis report on the 2024 plan to issue A-shares to specific targets
Plan to issue A shares to specific targets in 2024
Explanation about the investment of funds raised this time in the field of scientific and technological innovation
Announcement on the issuance of A shares to specific targets in 2024, diluted immediate returns and compensation measures and commitments of related entities
Notice regarding the provision of financial support or compensation to investors directly or through stakeholders participating in the subscription in this offering
Notice on how securities regulators and exchanges have been penalized or taken regulatory measures in the last five years
Minsheng Securities's inspection opinions on Borui Pharmaceutical's signing of conditionally effective share subscription agreements with specific targets and related transactions
Announcement on signing conditionally effective share subscription agreements and related transactions with specific targets
Announcement on Yuan Jiandong's issuance of a letter of commitment on matters relating to the company's issuance of shares to specific targets in 2024
Notice on requesting the shareholders' meeting to agree to exempt subscribers from issuing offers
Announcement on changes in the stock raising project to issue shares to specific targets using a simple procedure
Minsheng Securities's inspection opinion on Borui Pharmaceutical's changes to fund-raising investment projects
Announcement on additional provisional proposals for the 2023 Annual General Meeting of Shareholders
Analysis
Price Target
No Data
